MedPath

A repeatedly applied study of BBI-4000 in patients with primary hyperhidrosis

Phase 1
Completed
Conditions
Primary axillary hyperhidrosis
Registration Number
JPRN-jRCT2080224187
Lead Sponsor
KAKEN PHARMACEUTICAL, CO., LTD.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
25
Inclusion Criteria

Patients diagnosed as primary axillary hyperhidrosis

Exclusion Criteria

Secondary hyperhidrosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath